/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES./
MONTREAL, Feb. 3 /CNW Telbec/ - OPMEDIC GROUP Inc. ("OPMEDIC GROUP" or
the "Company") (TSX: "OMG"), a healthcare-related company in fertility,
laboratories and surgeries providing services and facilities to patients and
surgeons, is pleased to announce its first dividend to the shareholders.
DECLARATION OF DIVIDEND ON COMMON SHARES
The Company today announced that its Board of Directors has declared a
cash dividend of $0.015 per share payable February 27, 2009 to shareholders of
record at the close of business on February 13, 2009. Future dividends are
subject to the discretion of the Board of Directors.
"The Company is pleased to be able to declare a dividend as a way to
deliver value to our shareholders. Our strong cash generation in the previous
quarters gave us the ability to declare the dividend and continue at the same
time our growth strategy focused on the consolidation of the Company's
presence in the Quebec market and by extending our activities, either by
opening new facilities or by well targeted acquisitions." said Dr Pierre
St-Michel, President and Chief Executive Officer.
Detailed financial results can be accessed on the OPMEDIC GROUP web site
About OPMEDIC GROUP
OPMEDIC GROUP is a company incorporated under the laws of the Province
of Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".
This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offerting would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
The Content of this press release has not been approved by nor submitted
to the TSX which assumes no liability therefore.
For further information:
For further information: Jean-Marc Lachance, Vice President Finance and
Chief Financial Officer, (514) 345-8535, x 2260, email@example.com